Harnessing CAR T Cells for Children With Brain Cancers
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and...
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and...
The summer, espionage-themed edition of From the Bench highlights in vivo cancer therapies that spring into action inside the...
A study suggests that modifying a patient’s gut microbiome could make their cancer more likely to respond to CAR...
For April 2025, the editors of AACR's 10 journals highlighted studies on evolution in glioblastoma, new cancer treatment approaches,...
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...